ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PROF vs KTWO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Profound Medical Corp. (NASDAQ) VS. K2 Capital Acquisition Corporation Class A Ordinary Share (NASDAQ) • 15-METRIC TALLY: PROF 1 — KTWO 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PROF VS. KTWO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PROF KTWO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 70.80% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -17.93% — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 65.30% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.97 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 — — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.0 59.4 -12.40 KTWO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $214.1M $202.8M $11.3M PROF /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PROF REV KTWO REV PROF GROSS % KTWO GROSS % PROF FCF KTWO FCF
FY 2025 $16.1M $0 70.8% — -$38.4M —
FY 2024 $9.7M — 72.2% — -$23.5M —
FY 2023 $5.9M — — — -$22.6M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PROF // BETA —
KTWO // BETA —